Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Enterococcus hirae Bacteremia in an Infant: Case Report and Review of the Literature.

Brayer S, Linn A, Holt S, Ellery K, Mitchell S, Williams J.

J Pediatric Infect Dis Soc. 2019 Jun 18. pii: piz028. doi: 10.1093/jpids/piz028. [Epub ahead of print]


Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas.

Garandeau D, Noujarède J, Leclerc J, Imbert C, Garcia V, Bats ML, Rambow F, Gilhodes J, Filleron T, Meyer N, Brayer S, Arcucci S, Tartare-Deckert S, Ségui B, Marine JC, Levade T, Bertolotto C, Andrieu-Abadie N.

Mol Cancer Ther. 2019 Feb;18(2):289-300. doi: 10.1158/1535-7163.MCT-17-1141. Epub 2018 Nov 27.


Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.

Keller L, Guibert N, Casanova A, Brayer S, Farella M, Delaunay M, Gilhodes J, Martin E, Balagué G, Favre G, Pradines A, Meyer N.

Acta Derm Venereol. 2019 Feb 1;99(2):206-210. doi: 10.2340/00015555-3080.


The pro-apoptotic BAX protein influences cell growth and differentiation from the nucleus in healthy interphasic cells.

Brayer S, Joannes A, Jaillet M, Gregianin E, Mahmoudi S, Marchal Sommé J, Fabre A, Mordant P, Cazes A, Crestani B, Mailleux AA.

Cell Cycle. 2017;16(21):2108-2118. doi: 10.1080/15384101.2017.1371882. Epub 2017 Sep 21.


FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.

Joannes A, Brayer S, Besnard V, Marchal-Sommé J, Jaillet M, Mordant P, Mal H, Borie R, Crestani B, Mailleux AA.

Am J Physiol Lung Cell Mol Physiol. 2016 Apr 1;310(7):L615-29. doi: 10.1152/ajplung.00185.2015. Epub 2016 Jan 15.


Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy.

Brayer SW, Reddy KR.

Expert Rev Gastroenterol Hepatol. 2015 May;9(5):547-58. doi: 10.1586/17474124.2015.1032938. Epub 2015 Apr 6. Review.


Visual Priming Enhances the Effects of Nonspatial Cognitive Rehabilitation Training on Spatial Learning After Experimental Traumatic Brain Injury.

Edwards CM, Kumar K, Koesarie K, Brough E, Ritter AC, Brayer SW, Thiels E, Skidmore ER, Wagner AK.

Neurorehabil Neural Repair. 2015 Oct;29(9):897-906. doi: 10.1177/1545968315570326. Epub 2015 Feb 9.


Forkhead Box F1 represses cell growth and inhibits COL1 and ARPC2 expression in lung fibroblasts in vitro.

Melboucy-Belkhir S, Pradère P, Tadbiri S, Habib S, Bacrot A, Brayer S, Mari B, Besnard V, Mailleux A, Guenther A, Castier Y, Mal H, Crestani B, Plantier L.

Am J Physiol Lung Cell Mol Physiol. 2014 Dec 1;307(11):L838-47. doi: 10.1152/ajplung.00012.2014. Epub 2014 Sep 26.


Developing a clinically relevant model of cognitive training after experimental traumatic brain injury.

Brayer SW, Ketcham S, Zou H, Hurwitz M, Henderson C, Fuletra J, Kumar K, Skidmore E, Thiels E, Wagner AK.

Neurorehabil Neural Repair. 2015 Jun;29(5):483-95. doi: 10.1177/1545968314550367. Epub 2014 Sep 19.


Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.

Moshai EF, Wémeau-Stervinou L, Cigna N, Brayer S, Sommé JM, Crestani B, Mailleux AA.

Am J Respir Cell Mol Biol. 2014 Jul;51(1):11-25. doi: 10.1165/rcmb.2013-0154OC.


Non-spatial pre-training in the water maze as a clinically relevant model for evaluating learning and memory in experimental TBI.

Wagner AK, Brayer SW, Hurwitz M, Niyonkuru C, Zou H, Failla M, Arenth P, Manole MD, Skidmore E, Thiels E.

Neurobiol Learn Mem. 2013 Nov;106:71-86. doi: 10.1016/j.nlm.2013.07.006. Epub 2013 Jul 18.


Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury.

Zou H, Brayer SW, Hurwitz M, Niyonkuru C, Fowler LE, Wagner AK.

Neurorehabil Neural Repair. 2013 Nov-Dec;27(9):878-88. doi: 10.1177/1545968313491007. Epub 2013 Jun 27.


The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.

Cigna N, Farrokhi Moshai E, Brayer S, Marchal-Somme J, Wémeau-Stervinou L, Fabre A, Mal H, Lesèche G, Dehoux M, Soler P, Crestani B, Mailleux AA.

Am J Pathol. 2012 Dec;181(6):2126-37. doi: 10.1016/j.ajpath.2012.08.019. Epub 2012 Sep 29.


Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis.

Artaud-Macari E, Goven D, Brayer S, Hamimi A, Besnard V, Marchal-Somme J, Ali ZE, Crestani B, Kerdine-Römer S, Boutten A, Bonay M.

Antioxid Redox Signal. 2013 Jan 1;18(1):66-79. doi: 10.1089/ars.2011.4240. Epub 2012 Aug 6.


A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor.

Chabot S, Jabrane-Ferrat N, Bigot K, Tabiasco J, Provost A, Golzio M, Noman MZ, Giustiniani J, Bellard E, Brayer S, Aguerre-Girr M, Meggetto F, Giuriato S, Malecaze F, Galiacy S, Jaïs JP, Chose O, Kadouche J, Chouaib S, Teissié J, Abitbol M, Bensussan A, Le Bouteiller P.

J Exp Med. 2011 May 9;208(5):973-86. doi: 10.1084/jem.20100810. Epub 2011 Apr 11.

Supplemental Content

Loading ...
Support Center